NYSE$KVUE

Kenvue Inc · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Headline financials

Total Revenue

$15.1B

Previous: $3.73B+303.3%
EPS (adj)

$1.21

Previous: $0.22+456.1%
Organic Sales Growth

6.2%

No prior period
Capital Expenditures

$295M

No prior period
Free Cash Flow

$39M

No prior period
Net Income

$2.08B

Previous: $411M+405.6%
Operating Income

$2.92B

Previous: $506M+477.1%
Gross Profit

$8.42B

Previous: $1.98B+324.6%
Cash & Equivalents

$740M

No prior period
Stock-Based Comp

$141M

No prior period

Revenue & EPS history

Kenvue · Revenue · Quarterly

$15.1B

Q4 2022+303.3%vs Q4 2021
Beat estimate in 7 of 12 quarters(58%)
ActualEstimate

Revenue by segment

Kenvue · $3.77B total across 3 segments · Q4 2022

  • Self Care
    $1.57B
  • Essential Health
    $1.11B
  • Skin Health & Beauty
    $1.09B

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

+2.0%

Avg return

Earnings day

+3.1%

Avg return

5 days after

+3.0%

Avg return

30 days after

57%

8 / 14 earnings

Positive

+15.7%

Q3 2025

Best reaction

-7.7%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.0%-1.2%
Q4 2025+0.9%+2.9%-5.5%
Q3 2025+15.7%+17.5%+18.1%
Q2 2025+1.5%+2.1%-13.2%
Q1 2025+4.3%+2.4%-6.0%
Q4 2024-4.5%+0.8%+12.9%
Q3 2024+5.2%+5.1%+1.5%
Q2 2024+13.4%+15.6%+23.7%
Q1 2024+7.2%+7.7%-2.4%
Q4 2022-0.2%+3.1%+12.9%
Q4 2023-5.8%-6.2%-2.4%
Q3 2023-7.7%-5.7%+2.6%
Q2 2023-4.0%+0.5%-8.5%
Q1 2023-0.5%-0.8%+4.5%
Q3 2022
Q2 2022
Q1 2022
Q4 2021

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro